Does APIXABAN Cause Product supply issue? 35 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Product supply issue have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
35
Reports of Product supply issue with APIXABAN
0.0%
of all APIXABAN reports
11
Deaths
7
Hospitalizations
How Dangerous Is Product supply issue From APIXABAN?
Of the 35 reports, 11 (31.4%) resulted in death, 7 (20.0%) required hospitalization.
Is Product supply issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Product supply issue?
SECUKINUMAB (357)
LENALIDOMIDE (310)
CANNABIDIOL (298)
APREMILAST (266)
HUMAN IMMUNOGLOBULIN G (169)
OFATUMUMAB (149)
ELTROMBOPAG OLAMINE (140)
HUMAN C1-ESTERASE INHIBITOR (117)
OXCARBAZEPINE (109)
CARBAMAZEPINE (98)
Which APIXABAN Alternatives Have Lower Product supply issue Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ